RECENT PLACEMENT

Occam Recruits CSO for Public Gene Therapy Company, Adverum

Occam Recruits CSO for Public Gene Therapy Company, Adverum

In February 2024, Occam recruited Romuald “Romu” Corbau, PhD as Chief Scientific Officer for Adverum Biotechnologies (Nasdaq: ADVM).

Corbau has over 25 years of life science experience, ranging from startups to global pharmaceutical companies in the United States and Europe.  He joins Adverum from GenEdit, where he served as Chief Scientific Officer.  Prior to joining GenEdit, Corbau progressed from Vice President of Research to Chief Scientific Officer at Freeline.  Before GenEdit, Corbau was the Translational Lead at Spark Therapeutics and held various research positions at Pfizer, CISTIM in Belgium, and Children’s Hospital of Philadelphia.

‍

Recent Placements

  1. John Reynders as Chief Data Sciences Officer of Neumora
  2. Jevan Soo Lenox as Chief People Officer at insitro
  3. Jorge Bartolome as CEO at Areteia Therapeutics
  4. Kevin Coveney as CFO of Enveric Biosciences
  5. Gurpreet Ratra as CBO at Skyline
About Occam Global

Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.